Literature DB >> 36213636

Whole genome sequencing analysis of SARS-CoV-2 from Malaysia: From alpha to Omicron.

Choo Yee Yu1, Sie Yeng Wong2, Nancy Woan Charn Liew1, Narcisse Joseph2, Zunita Zakaria3,4, Isa Nurulfiza1,5, Hui Jen Soe6, Rachna Kairon6, Syafinaz Amin-Nordin2, Hui Yee Chee2.   

Abstract

Countries around the world are gearing for the transition of the coronavirus disease 2019 (COVID-19) from pandemic to endemic phase but the emergence of new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants could lead to a prolonged pandemic. SARS-CoV-2 has continued to evolve as it optimizes its adaptation to the human host and the successive waves of COVID-19 have been linked to the explosion of particular variant of concern. As the genetic diversity and epidemiological landscape of SARS-CoV-2 differ from country to country, this study aims to provide insights into the variants that are circulating in Malaysia. Whole genome sequencing was performed for 204 SARS-CoV-2 from COVID-19 cases and an additional 18,667 SARS-CoV-2 genome sequences were retrieved from the GISAID EpiCoV database for clade, lineage and genetic variation analyses. Complete genome sequences with high coverage were then used for phylogeny investigation and the resulting phylogenetic tree was constructed from 8,716 sequences. We found that the different waves of COVID-19 in Malaysia were dominated by different clades with the L and O clade for first and second wave, respectively, whereas the progressive replacement by G, GH, and GK of the GRA clade were observed in the subsequence waves. Continuous monitoring of the genetic diversity of SARS-CoV-2 is important to identify the emergence and dominance of new variant in different locality so that the appropriate countermeasures can be taken to effectively contain the spread of SARS-CoV-2.
Copyright © 2022 Yu, Wong, Liew, Joseph, Zakaria, Nurulfiza, Soe, Kairon, Amin-Nordin and Chee.

Entities:  

Keywords:  COVID-19; Malaysia variant; SARS-CoV-2 genome; VOC; clade replacement; epidemiology; genetic diversity\keywordbelowspace-30pt

Year:  2022        PMID: 36213636      PMCID: PMC9537942          DOI: 10.3389/fmed.2022.1001022

Source DB:  PubMed          Journal:  Front Med (Lausanne)        ISSN: 2296-858X


  57 in total

1.  Covid-19: The E484K mutation and the risks it poses.

Authors:  Jacqui Wise
Journal:  BMJ       Date:  2021-02-05

2.  IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies.

Authors:  Lam-Tung Nguyen; Heiko A Schmidt; Arndt von Haeseler; Bui Quang Minh
Journal:  Mol Biol Evol       Date:  2014-11-03       Impact factor: 16.240

3.  Data, disease and diplomacy: GISAID's innovative contribution to global health.

Authors:  Stefan Elbe; Gemma Buckland-Merrett
Journal:  Glob Chall       Date:  2017-01-10

4.  Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020.

Authors:  Kathy Leung; Marcus Hh Shum; Gabriel M Leung; Tommy Ty Lam; Joseph T Wu
Journal:  Euro Surveill       Date:  2021-01

5.  The Functional Classification of ORF8 in SARS-CoV-2 Replication, Immune Evasion, and Viral Pathogenesis Inferred through Phylogenetic Profiling.

Authors:  Muhamad Fahmi; Hiromu Kitagawa; Gen Yasui; Yukihiko Kubota; Masahiro Ito
Journal:  Evol Bioinform Online       Date:  2021-03-15       Impact factor: 1.625

6.  The Emergence of the Omicron (B.1.1.529) SARS-CoV-2 Variant: What is the Impact on the Continued Pandemic?

Authors:  Jaffar A Al-Tawfiq; Van-Thuan Hoang; Nhat Le Bui; Dinh-Toi Chu; Ziad A Memish
Journal:  J Epidemiol Glob Health       Date:  2022-01-28

7.  Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance.

Authors:  Jiahui Chen; Rui Wang; Nancy Benovich Gilby; Guo-Wei Wei
Journal:  J Chem Inf Model       Date:  2022-01-06       Impact factor: 4.956

8.  TreeTime: Maximum-likelihood phylodynamic analysis.

Authors:  Pavel Sagulenko; Vadim Puller; Richard A Neher
Journal:  Virus Evol       Date:  2018-01-08

9.  Identification of novel mutations in SARS-COV-2 isolates from Turkey.

Authors:  Shazia Rehman; Tariq Mahmood; Ejaz Aziz; Riffat Batool
Journal:  Arch Virol       Date:  2020-10-06       Impact factor: 2.574

10.  Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum.

Authors:  Chang Liu; Helen M Ginn; Wanwisa Dejnirattisai; Piyada Supasa; Beibei Wang; Aekkachai Tuekprakhon; Rungtiwa Nutalai; Daming Zhou; Alexander J Mentzer; Yuguang Zhao; Helen M E Duyvesteyn; César López-Camacho; Jose Slon-Campos; Thomas S Walter; Donal Skelly; Sile Ann Johnson; Thomas G Ritter; Chris Mason; Sue Ann Costa Clemens; Felipe Gomes Naveca; Valdinete Nascimento; Fernanda Nascimento; Cristiano Fernandes da Costa; Paola Cristina Resende; Alex Pauvolid-Correa; Marilda M Siqueira; Christina Dold; Nigel Temperton; Tao Dong; Andrew J Pollard; Julian C Knight; Derrick Crook; Teresa Lambe; Elizabeth Clutterbuck; Sagida Bibi; Amy Flaxman; Mustapha Bittaye; Sandra Belij-Rammerstorfer; Sarah C Gilbert; Tariq Malik; Miles W Carroll; Paul Klenerman; Eleanor Barnes; Susanna J Dunachie; Vicky Baillie; Natali Serafin; Zanele Ditse; Kelly Da Silva; Neil G Paterson; Mark A Williams; David R Hall; Shabir Madhi; Marta C Nunes; Philip Goulder; Elizabeth E Fry; Juthathip Mongkolsapaya; Jingshan Ren; David I Stuart; Gavin R Screaton
Journal:  Cell       Date:  2021-06-17       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.